The industry has begun to incorporate patient engagement point solutions into clinical studies, yet none have been widely adopted. Multiple point solutions can be used across each study - typically provided by varying vendors. By utilizing a unified platform approach, the need for integrating disparate solutions and reconciliation of data is reduced. In this session, learn how multiple virtualization technologies such as video visits, eCOA or eConsent can all be used through a single platform to enhance both the site and patient experience.

Patient centricity isn't just a word Medidata uses, but an action taken by incorporating the patient's perspective into designing products and solutions. Patient advisors and advocates join the Medidata team at Design Studio workshops in order to capture their feedback on proposed technologies and solutions.

Medidata is improving trial efficiencies with a suite of patient cloud tools such as a global eCOA library and integration of wearable sensors. These virtual data capturing tools will be available to patients through a Rave patient portal, enabling the virtualization of clinical trials. Through the process of Patient Centricity by Design, the patient's perspective has carefully been considered and infused throughout the development of these solutions.

Kelly Mckee of Medidata, leads a panel discussion with Jeff Kingsly DO, CEO of IACT Health, and Anne Marie Mercurio, a patient advocate to discuss the challenges and opportunities when using virtualizing technologies in clinical trials. Together they discuss lessons learned from the use of live video visits to enable clinical trial continuity along with the possibility of hybrid trials becoming the new normal for the near future.

How do you develop COVID-19 vaccines and treatments safely in less than a year, virtually? The answer is decentralized technologies, which allows for patient participation outside of the traditional trial site and virtual clinical oversight activities, on a single platform. This session demonstrates how remote data capture linked to real time data insights helps customers get life-saving vaccines and treatments to patients in record time.

Research has shown that patients are likely to participate when they are aware of clinical trial opportunities and are empowered with knowledge to optimize their engagement experiences. In rare diseases, these problems are further amplified. In this webinar, learn how Medidata is improving access to, and optimizing experiences in, clinical trials through myMedidata Patient Registries.

Prior to the global pandemic, virtualization technologies were slow to adoption, with most large scale trials operating in traditional clinical settings. Now, the virtualization of clinical trials has become the industry’s new focus. In this webinar we’ll be exploring the changing paradigm of study conduct to enable virtualization of clinical trials, both for patients and sites, and why it has become the industry’s new focus.

From the front lines, hear real-life success stories in the strategy and execution of Randomized Trial Supply Management (RTSM). This webinar will showcase how joining forces with the right partner allowed these pharma professionals to learn and deliver best practices on design considerations, reducing UAT scope and timelines for RTSM builds among the rigors and day to day challenges of study conduct. You will learn best practices related to supply management strategies for multiple enrollment, limited supply, and expiry date scenarios.

As clinical trials have become even more complex over the last year, having control of the financial health of your clinical trials has never been more important.  One of the most common mistakes that is made when it comes to financial management of clinical trials is separating the budget planning, negotiation and amendment process from the site payment process. Leveraging the right technology, tools and expertise to bring those processes together is possible through the Medidata platform and our team of experts.

During COVID-19, regulators and sponsors show pragmatism and flexibility in terms of mitigating challenges in the current climate. The combination of digital distribution, innovation, and flexibility enabled the clinical trial community to expedite drug development during the COVID-19 pandemic while also minimizing risks to patient and trial success. During this session, we will explore how new and reimagined technology innovations are addressing the impact of COVID-19.